Rep. Ted Budd Sponsors Mainstreaming Addiction Treatment Act

Washington, D.C. -- Today, Rep. Ted Budd (R-NC) co-sponsored H.R.1384, the Mainstreaming Addiction Treatment Act of 2021. This bipartisan bill would remove the outdated and burdensome regulation that restricts access to buprenorphine, one of the most widely-used medications to treat opioid addiction.


Rep. Budd said in a statement:

“More than 93,000 overdose deaths occurred in our country last year. This tragic situation is bound to get worse if Congress doesn’t act. We need to make it easier for doctors to get life-saving treatments to folks struggling with addiction and no government barriers should stand in the way.”

 

Background:

  • Under current law, providers must receive a waiver to prescribe buprenorphine to treat opioid addiction. 

  • This outdated waiver requirement limits access, and reflects a longstanding stigma around substance use treatment.

  • 22 state departments of health and 39 state Attorneys General have advocated for removal of the waiver requirement. 


The Mainstreaming Addiction Treatment (MAT) Act would:

  • Eliminate the requirement that practitioners apply for a waiver through the Drug Enforcement Administration in order to prescribe buprenorphine for substance use disorder treatment. Practitioners would still be subject to their state’s licensure requirements.

  • Require that the Secretary of Health and Human Services conduct a national campaign to educate practitioners and encourage integration of substance use treatment into their practices.

Stay Connected

Use the form below to sign up for my newsletter and get the latest news and updates directly to your inbox.